Materials and Measurements
All chemicals were purchase from Aldrich. Dimethylformamide (DMF) was distilled after drying.
Dialysis tube (cut-off molecular weight of 3000; Spectrum Laboratories, Inc.) was used for the purification of iNOP-7 derivatives.
1 H-NMR was recorded on an Oxford 400 NMR spectrometer.
Chemical shifts (δ = 0 ppm) were referred to TMS with the residual proton of the deuterated solvent.
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) spectra were recorded on a Waters Micromass MALDI-LR instrument. 2, 5-Dihydroxybenzoic acid (15 mg/ml in 50% acetanitrile solution containing 0.1% trifluoroacetic acid) was used as matrix. A mixture of the sample solution (1mL, 1.0 mg/ml in 50% acetanitrile solution containing 0.1% trifluoroacetic acid) and the matrix solution was applied to the MALDI probe. The sample was allowed to dry by air evaporation and was subjected to MS analysis.
Synthesis

3-(2-tert-butoxycarbonylamino-ethyldisulfanyl)-propanoic acid (spacer I)
Ethanol solution (4 ml) of 3-mercaptopropionic acid (0.18 g, 1.7 mmol) was added dropwise to 2,2'-dithiodipyridine (0.75 g, 3.4mmol in 6ml ethanol) over 20 min by stirring vigorously. Glacial acetic acid (80 ul) was added and the reaction mixture was stirred at room temperature for 2 hours. Then the solvent was removed, and product was purified by basic aluminum oxide chromatography. The columnm was first washed using dichloromethane and ethanol (3:2) to flow byproducts and impurities, then the product was eluted using dichloromethane and ethanol (3:2) containing 4% acidic acid to give 3-(2-Pyridyldithio)propionic acid as a white foam (249 mg, yield: 68%) (1) . 3-(2-Pyridyldithio)propionic acid (405 mg, 1.9 mmol) was reacted with 2-(Boc-amino)ethanethiol (330 mg, 1.9 mmol) in ethanol (4 ml) to give 3-(2-tert-butoxycarbonylamino-ethyldisulfanyl)-propanoic acid (400 mg, yield: 75%). 1H NMR: 
Synthesis of iNOP-7DS
A mixture of iNOP-7 (20mg, 3.4µmol), spacer I (72mg, 256µmol) and DIEA (0.49 ml, 2.8 mmol) was suspended in 0.6 ml DMF under nitrogen atmosphere. After the suspension was cooled to 0 ºC, BOP (221mg) was added. The reaction was performed at 0 ºC for 30 min and then at room temperature for 24 h.
Then the solvent was removed under reduced pressure, and the obtained syrup was washed repeatedly with ethyl acetate. The product was further purified by recrystalization from methanol -ethyl acetate (1 mL:15 mL) system to give a white powder. After TFA deprotection, 34mg of white powdery iNOP-7DS
was obtained. MALDI-TOF mass spectrum shows two broad peaks. The major peak ce ntered at m/z 9432.0 corresponds to a highly substituted moelcule, and the one at m/z 4730.9 corresponds to [M+2H + ].
Biological Experiment Methods
siRNAs
All siRNAs used in in vivo studies were chemically synthesized using silyl ethers to protect 5′-hydroxyls and acid-labile orthoesters to protect 2′-hydroxyls (2′-ACE) (Dharmacon, Lafayette, CO). After deprotection and purification, siRNA strands were annealed as described previously (2) . ApoB siRNA DDB1 siRNA: antisense 5′-UAACAUGAGAACUCUUGUC-3′, sense 5'-GACAAGAGUUCUCAUGUUA
In Vitro RNAi Activity of iNOP-7DS
For in vitro siRNA transfection, iNOP-7DS (1.0 uM ~ 1.5 uM final concentration) was complexed to siRNA (50 nM final concentration) and incubated at r.t. for 20 min before placed on cells. FL83B (mouse hepatocytes) cells were maintained at 37°C with 5% CO 2 in F-12K culture medium (ATCC, Manassas, VA) supplemented with 10% fetal bovine serum, 100 U mL -1 penicillin and 100 µg mL -1 streptomycin.
Cells were regularly passaged and plated in 6-well culture plates for 16 h before transfection at 70%
confluency. Cells were transfected with 1 mL per well of complex (siRNA-nanoparticles) for 4 h at 37°C.
Efficiency of RNAi was determined as described previously (3, 4) .
HCT116 cells and HepG2 cells were maintained at 37 oC with 5% Co2 in DMEM medium supplemented with 10% fetal bovine serum, 100 U mL -1 penicillin and 100 µg mL -1 streptomycin. Cells were regularly passaged and plated in 6-well culture plates for 16 h before transfection at 70% confluency.
Cells were transfected with 1 mL per well of complex (siRNA-nanoparticles) for 4 h at 37°C. Efficiency of RNAi was determined as described previously.
In Vivo Silencing
All animal procedures were approved by the Institutional Animal Care and Use Committee (University of Massachusetts Medical School). Six-to eight-week-old male C57BL/6 mice (Charles River Laboratories, Wilmington, MA) were maintained under a 12 h dark cycle in a pathogen-free animal facility. Mice were administrated with either phosphate buffered saline pH 7.4 (PBS) or iNOP-7DS containing mismatch siRNA or perfect match siRNA at 1 mg kg -1 as bolus intravenous injection via the lateral tail vein. Fortyeight hours after the injection, liver, spleen, kidney, lung and plasma were collected and stored in -80°C until analysis.
Quantitative PCR
In Vivo Interferon Induction
To assess for any nonspecific immune response to injected siRNA complexed with nanoparticles, mouse liver RNA was analyzed for expression of the IFN-inducible genes by quantitative RT-PCR. Serum levels of mouse IFN-α were measured by using a sandwich ELISA kit according to the manufacturer's instructions (PBL Biomedical, Piscataway, NJ) (5).
